CME · Cme Group Inc. - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · CME

1Y 3Y 5Y Max

Annual Quarterly

Income Statement

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$6.52B	$6.13B	$5.58B	$5.02B	$4.69B	$4.88B
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
R&D	-	-	-	-	-	-
SG&A	-	-	-	-	-	-
Total Operating Expenses	$2.29B	$2.20B	$2.14B	$2.00B	$2.04B	$2.25B
D&A	$107.50M	$115.10M	$126.00M	$134.90M	$147.80M	$153.20M
Operating Income	$4.23B	$3.93B	$3.44B	$3.02B	$2.65B	$2.64B
Interest Expense	-	-	-	-	-	-
Income Tax	$1.26B	$1.02B	$927.40M	$799.30M	$736.70M	$615.70M
Net Income	$4.07B	$3.53B	$3.23B	$2.69B	$2.64B	$2.11B
EPS - Basic	$11.18	$9.69	$8.87	$7.41	$7.30	$5.88
EPS - Diluted	$11.16	$9.67	$8.86	$7.40	$7.29	$5.87

Balance Sheet

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Cash & Equivalents	$4.42B	$2.89B	$2.91B	$2.72B	$2.83B	$1.63B
Accounts Receivable	$639.20M	$573.10M	$535.60M	$483.20M	$434.50M	$461.30M
Inventory	-	-	-	-	-	-
Accounts Payable	$71.80M	$79.90M	$90.60M	$121.40M	$48.80M	$69.30M
Current Assets	$165.36B	$103.03B	$94.89B	$139.08B	$161.76B	$89.28B
Total Assets	$198.42B	$137.45B	$129.71B	$174.18B	$196.78B	$124.66B
Current Liabilities	$160.30B	$102.31B	$93.42B	$137.69B	$160.40B	$88.20B
Long-term Debt	-	-	-	-	-	-
Total Liabilities	$169.70B	$110.96B	$102.97B	$147.30B	$169.38B	$98.31B
Stockholders' Equity	$28.73B	$26.49B	$26.74B	$26.88B	$27.40B	$26.32B
Retained Earnings	$6.43B	$4.19B	$4.46B	$4.75B	$5.15B	$5.00B

Cash Flow

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Operating Cash Flow	$4.28B	$3.69B	$3.45B	$3.06B	$2.40B	$2.72B
Investing Cash Flow	$1.50B	($82.60M)	$20.90M	($489.80M)	$58.40M	($175.50M)
Financing Cash Flow	$56.51B	$5.08B	($48.34B)	($25.38B)	$69.91B	($2.46B)
CapEx	$83.50M	$94.00M	$76.40M	$89.70M	$127.20M	$197.50M
Free Cash Flow	$4.19B	$3.60B	$3.38B	$2.97B	$2.28B	$2.52B

Ratios

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Profitability
Gross margin	-	-	-	-	-	-
Operating margin	64.9%	64.1%	61.6%	60.1%	56.4%	54.0%
EBITDA margin	66.5%	66.0%	63.8%	62.8%	59.6%	57.1%
Net margin	62.5%	57.5%	57.8%	53.6%	56.2%	43.1%
Free cash flow margin	64.3%	58.7%	60.5%	59.1%	48.5%	51.6%
FCF / Net income	1.03	1.02	1.05	1.10	0.86	1.20
R&D / Revenue	-	-	-	-	-	-
SG&A / Revenue	-	-	-	-	-	-
Effective tax rate	23.6%	22.4%	22.3%	22.9%	21.8%	22.6%
Return on assets	2.1%	2.6%	2.5%	1.5%	1.3%	1.7%
Return on equity	14.2%	13.3%	12.1%	10.0%	9.6%	8.0%
Return on invested capital	-	-	-	-	-	-
Liquidity
Current ratio	1.03	1.01	1.02	1.01	1.01	1.01
Quick ratio	1.03	1.01	1.02	1.01	1.01	1.01
Cash ratio	0.03	0.03	0.03	0.02	0.02	0.02
Leverage
Debt / Equity	-	-	-	-	-	-
Debt / Assets	-	-	-	-	-	-
Debt / EBITDA	-	-	-	-	-	-
Interest coverage	-	-	-	-	-	-
Equity multiplier	6.91	5.19	4.85	6.48	7.18	4.74
Liabilities / Assets	0.86	0.81	0.79	0.85	0.86	0.79
Efficiency
Asset turnover	0.03	0.04	0.04	0.03	0.02	0.04
Inventory turnover	-	-	-	-	-	-
Days sales outstanding	36d	34d	35d	35d	34d	34d
Days inventory outstanding	-	-	-	-	-	-
Days payable outstanding	-	-	-	-	-	-
Cash conversion cycle	-	-	-	-	-	-
Valuation
P / E	24.5x	24.0x	23.8x	22.7x	31.3x	31.0x
P / B	3.4x	3.2x	2.8x	2.2x	3.0x	2.5x
P / S	15.1x	13.6x	13.6x	12.0x	17.5x	13.4x
EV / EBITDA	21.7x	19.9x	20.4x	18.3x	28.3x	22.8x
Growth
Revenue growth (YoY)	6.4%	9.9%	11.1%	7.0%	-4.0%	0.3%
Revenue CAGR (3y)	9.1%	9.3%	4.5%	1.0%	2.9%	10.2%
Revenue CAGR (5y)	6.0%	4.7%	5.3%	6.6%	5.5%	8.0%
Gross profit growth (YoY)	-	-	-	-	-	-
Operating income growth (YoY)	7.6%	14.4%	13.9%	14.0%	0.3%	1.9%
Net income growth (YoY)	15.5%	9.3%	19.9%	2.1%	25.2%	-0.5%
EPS growth (YoY)	15.4%	9.1%	19.7%	1.5%	24.2%	-0.7%
EPS CAGR (3y)	14.7%	9.9%	14.7%	7.8%	8.5%	-21.1%
EPS CAGR (5y)	13.7%	10.3%	9.2%	-9.1%	10.0%	9.7%
FCF growth (YoY)	16.6%	6.5%	13.9%	30.4%	-9.6%	3.7%
FCF CAGR (5y)	10.7%	8.2%	7.8%	11.0%	7.0%	12.4%
Book value growth (YoY)	8.5%	-0.9%	-0.5%	-1.9%	4.1%	0.7%

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2025-12-31.

Product / service

$6.52B total

Clearingandtransactionfees$5.28B · 81.0%

Market Data$803.10M · 12.3%

Other Revenue$436.40M · 6.7%

Stability scores

Altman Z′

FY 2025 · bankruptcy risk

0.22

Distress

Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.

Piotroski F-score

FY 2025 · 9-point quality

5/9

Neutral

✓Net income positive
✓Operating cash flow positive
✗ROA improved YoY
✓Cash flow > net income
-Long-term debt decreased
✓Current ratio improved
✓No share dilution
-Gross margin improved
✗Asset turnover improved

Peer comparison

Same SIC group: Security & Commodity Brokers, Dealers, Exchanges & Services

Company	Revenue (last FY)	Net margin	ROE
ICE	$12.64B	26.2%	11.5%
LPLA	$16.99B	5.1%	16.1%
TW	$2.05B	39.6%	12.5%
SNEX	$132.38B	0.2%	12.9%
NDAQ	$8.26B	21.6%	14.6%

Comparing CME GROUP INC. against the 5 most active filers in the same SIC group.

Dividends

$11.20/share trailing 12 months · +6.7% YoY

Ex-date	Per share
Mar 10, 2026	$7.4500
Dec 12, 2025	$1.2500
Sep 9, 2025	$1.2500
Jun 9, 2025	$1.2500
Mar 7, 2025	$1.2500
Dec 27, 2024	$5.8000
Dec 9, 2024	$1.1500
Sep 9, 2024	$1.1500
Jun 7, 2024	$1.1500
Mar 7, 2024	$1.1500
Dec 27, 2023	$5.2500
Dec 7, 2023	$1.1000
Sep 7, 2023	$1.1000
Jun 8, 2023	$1.1000
Mar 9, 2023	$1.1000
Dec 27, 2022	$4.5000
Dec 8, 2022	$1.0000
Sep 8, 2022	$1.0000
Jun 9, 2022	$1.0000
Mar 9, 2022	$1.0000
Dec 27, 2021	$3.2500
Dec 9, 2021	$0.9000
Sep 9, 2021	$0.9000
Jun 9, 2021	$0.9000